Skip to main content

Pseudo Gray Platelet Syndrome in a Patient with Acute Myocardial Infarction

Abstract

W e report a patient with pseudo gray platelet syndrome. He was admitted to our hospital because of acute myocardial infarction. He had platelets that were stained poorly and appeared gray and agranular under a light microscope. This appear-ance is a characteristic feature of gray platelet syndrome. However, in this case, no bleeding tendency was observed and the abnormality was dependent on the presence of ethylenediamine tetra acetic acid (EDTA) and did not occur in a nonantico-agulant, trisodium citrate dihydrate and heparin. There are few reports of this pseudo gray platelet syndrome and, in fact, this is the first report of the syndrome in Japan, possibly because the phenomenon has been unrecognized and passed over in the past.Int J Hematol. 2002;76:376-378.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Raccuglia G. Grey platelet syndrome: a variety of qualitative platelet disorder.Am J Med. 1971; 51: 818–828.

    Article  CAS  PubMed  Google Scholar 

  2. 2.

    Gerrard JM, Phillips DR, Rao GHR, et al. Biochemical studies of two patients with the gray platelet syndrome.J Clin Invest. 1980; 66: 102–109.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. 3.

    White JG. Ultrastructural studies of the gray platelet syndrome.Am J Pathol. 1979; 95: 455–462.

    Google Scholar 

  4. 4.

    Rosa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP. Gray platelet syndrome:demonstration of alpha granule membranes that can fuse with the cell surface.J Clin Invest. 1987; 80: 1138–1146.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. 5.

    Mori K, Suzuki S, Sugai K. Electron microscopic and functional studies on platelets in gray platelet syndrome.Tohoku J Exp Med. 1984; 143: 261–287.

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    Cockbill SR, Burmester HBC, Heptinstall S. Pseudo grey platelet syndrome-grey platelets due to degranulation in blood collected into EDTA.Eur J Haematol. 1988; 41: 326–333.

    Article  PubMed  CAS  Google Scholar 

  7. 7.

    Stavem P, Berg K. A macromolecular serum component acting on platelets in the presence of EDTA- ’platelet stain preventing factor.’Scand J Haematol. 1973; 10: 202–208.

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Mant MJ, Doery JCG, Gauldie J, Sims H. Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA.Scand J Haematol. 1975; 15: 161–170.

    Article  PubMed  CAS  Google Scholar 

  9. 9.

    Onder O, Weinstein A, Hoyer LW. Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents.Blood. 1980; 56: 177–182

    PubMed  CAS  Google Scholar 

  10. 10.

    Bizzaro N. EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up.Am J Hematol. 1995; 50: 103–109.

    Article  PubMed  CAS  Google Scholar 

  11. 11.

    Hoyt RH, Durie BG. Pseudothrombocytopenia induced by a monoclonal IgM kappa platelet agglutinin.Am J Hematol. 1989; 31: 50–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Shigeo Toyota or Norihiko Nakamura.

About this article

Cite this article

Toyota, S., Nakamura, N. & Dan, K. Pseudo Gray Platelet Syndrome in a Patient with Acute Myocardial Infarction. Int J Hematol 76, 376–378 (2002). https://doi.org/10.1007/BF02982700

Download citation

Key words

  • Pseudo gray platelet syndrome
  • EDTA